# Inositol Pms Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/inositol-pms-meta-analysis-evidence-review
Category: evidence-review
Summary: Inositol Pms Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic r
Last reviewed: 2026-06-27
Reviewed by: Migaku Evidence Review
# Inositol Pms Meta-analysis: What the Evidence Says

## Quick Answer

Inositol Pms Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Metabolomics in Multiple Sclerosis: Advances, Challenges, and Clinical Perspectives—A Systematic Review | systematic review | 1 | 2025-09-20 | 10.3390/ijms26189207 |
| Endocrine roles of vitamin D in female reproduction: Mechanisms and clinical implications. | research article | 4 | 2026-01-01 | 10.1177/17455057261446942 |

## What The Sources Report

- B lymphocytes also play a significant role in the development of MS, as evidenced by increased intrathecal immunoglobulin synthesis, reflected by the presence of oligoclonal bands (OCB) in the cerebrospinal fluid (CSF). [Smusz Jan (2025); evidence level 1]
- Cognitive deficits and depression are also common, affecting up to half of patients over the disease course, and contributing substantially to long-term disability and reduced quality of life. [Smusz Jan (2025); evidence level 1]
- This review of studies from 2013-2025 found consistent associations between low vitamin D status and various disorders in women of childbearing age. [Alsuwaidi A (2026); evidence level 4]
- In Premenstrual Syndrome (PMS), deficiency correlates with higher symptom severity, and evidence shows that supplementation significantly reduces total PMS scores, particularly improving mood-related domains. [Alsuwaidi A (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For inositol pms meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Smusz Jan (2025). Metabolomics in Multiple Sclerosis: Advances, Challenges, and Clinical Perspectives—A Systematic Review. DOI: 10.3390/ijms26189207. PMCID: PMC12471209. PMID: 41009767. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12471209/
- Alsuwaidi A (2026). Endocrine roles of vitamin D in female reproduction: Mechanisms and clinical implications.. DOI: 10.1177/17455057261446942. PMCID: PMC13133454. PMID: 42037530. https://pmc.ncbi.nlm.nih.gov/articles/PMC13133454/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.